Diagnostics That Change Patient Care | Dr. Russell Grant
BioTalk Unzipped1 Mars 2024

Diagnostics That Change Patient Care | Dr. Russell Grant

What happens when a scientist moves from pharmaceutical development into the world of clinical diagnostics?

Dr. Russell Grant joins BioTalk Unzipped to discuss a career that has taken him from the United Kingdom to the United States, from large pharmaceutical organizations into diagnostics, and across the evolving worlds of mass spectrometry and laboratory medicine.

Russ explains important differences between bioanalysis supporting clinical trials and laboratory testing used directly in patient care. He also shares his experience working through the extraordinary demands created by COVID-19 and why seemingly small improvements in laboratory efficiency can have meaningful consequences when multiplied across thousands of patients.

The conversation also examines a remarkable gene therapy story involving the restoration of hearing in a child with genetic hearing loss.

Beyond the technology, Russ discusses why diagnostics became such an important part of his career, the role scientific integrity plays in trustworthy research, and what concerns him about problems within scientific literature.

It is a conversation about science, healthcare, professional reinvention, and the responsibility researchers have to get the science right.

Topics explored
  • Moving from the UK to the United States and from pharma to diagnostics
  • Clinical-trial bioanalysis versus diagnostic laboratory medicine
  • The evolving role of mass spectrometry
  • Improving healthcare through better laboratory processes
  • Working through the COVID-19 pandemic
  • Gene therapy and genetic hearing loss
  • Scientific integrity and academic fraud
  • Why diagnostics can directly affect patient outcomes

Connect with Dr. Russell Grant

Dr. Russell Grant

https://www.linkedin.com/in/russell-grant-5144a26/

Connect with the hosts

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

New News

Lilly makes waves, says gene therapy restores hearing for child with genetic hearing loss:

https://www.fiercebiotech.com/biotech/lilly-makes-waves-says-gene-therapy-restored-hearing-child-genetic-hearing-loss

Image credits

David Gilmour, Getty Images

Sir Isaac Newton: https://en.wikipedia.org/wiki/Isaac_Newton

#biotechnology #diagnostics #science #innovation #patientcare

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(45)

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why is gene therapy still so difficult to manufacture at scale after decades of progress?Phillip Ramsey, Chief Technical Officer at Sangamo Therapeutics, joins BioTalk Unzipped for a candid conversati...

8 Aug 11min

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

A mother’s search for answers to her daughter’s relentless brain tumor led her into natural killer cell biology, cancer immunotherapy, and biotech entrepreneurship.Sponsored by Leucentra, https://leuc...

20 Juli 1h 4min

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

Oncology drug development is becoming more complex, and bioanalysis can no longer be treated as simple drug measurement.Sponsored by Leucentra, https://leucentra.com/Inspired by science, empowered by ...

11 Juni 29min

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Can artificial intelligence help make cancer therapies safer, more targeted, and more effective?In this episode of BioTalk Unzipped, Gregory Austin sits down with Dr. Daniel Reker, Assistant Professor...

25 Apr 50min

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why haven’t we cured cancer yet? A Genentech scientist explains the real reason.In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Bob Liu, Senior Principal Sci...

19 Mars 1h

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

Recorded October 31, 2025In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Kate Neville, immunologist turned seasoned biotech patent attorney at Marshall, Gers...

16 Feb 52min

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe sit down with Glafabra CEO: Dr. Chris Hopkins, geneticist, biochemist, and biotech entrepreneur, to explore the science a...

22 Dec 202549min

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Binodh DeSilva, Senior Vice President of Bioanalysis at Ultragenyx Pharmaceutical, to explore the science and...

23 Okt 202531min

Populärt inom Business & ekonomi

framgangspodden
badfluence
dynastin
varvet
rss-borsens-finest
uppgang-och-fall
avanzapodden
svd-tech-brief
rss-inga-dumma-fragor-om-pengar
fill-or-kill
borsmorgon
rss-dagen-med-di
lastbilspodden
tabberaset
rss-hos-psykologen
rss-kort-lang-analyspodden-fran-di
rikatillsammans-om-privatekonomi-rikedom-i-livet
borslunch-2
bathina-en-podcast
rss-veckans-trade